bioAffinity Technologies Inc (BIAFW) Stock Price & News

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	1.59M	1.35M	1.51M	1.07M
Cost of goods sold	900.13K	928.64K	1.09M	1.11M
Cost of revenue	900.13K	928.64K	1.09M	1.11M
Research and development expenses	668.81K	683.75K	837.46K	640.16K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.04M	3.24M	2.86M	2.76M
Operating expense	3.83M	4.04M	3.76M	3.47M
Total operating expenses	4.73M	4.97M	4.85M	4.58M
Operating income	-3.14M	-3.62M	-3.33M	-3.51M
Other non operating income	-3.98K	-8.94K	-22.89K	-1.76M
EBT including unusual items	-3.13M	-3.63M	-3.37M	-5.28M
EBT excluding unusual items	-3.13M	-3.63M	-3.37M	-5.28M
Income tax expense	3.18K	-	-	-
Effective tax rate	-0.10%	-	-	-
Other operating expenses	-	-	-	-
Net income	-3.14M	-3.63M	-3.37M	-5.28M
Net profit margin	-196.98%	-268.63%	-222.83%	-493.05%
Earnings per share	-	-	-	-
Interest and investment income	19.73K	10.03K	3.36K	4.73K
Interest expense	-13.07K	-14.72K	-11.69K	-10.71K
Net interest expenses	6.66K	-4.70K	-8.33K	-5.98K
Depreciation and amortization charges	123.66K	114.52K	61.56K	66.84K
EBITDA	-3.01M	-3.50M	-3.27M	-3.44M
Gain or loss from assets sale	-	-	-	-

Finance